Background: Ovarian cancer (OV) is a fatal gynecologic malignancy and has poor survival rate in women over the age of forty. In our study, we aimed to identify genes related to immune microenvironment regulations and explore genes associated with OV prognosis.Methods: The RNA-seq data of GDC TCGA Ovarian Cancer cohort of 376 patients was retrieved from website. Weighted gene co-expression network analysis (WGCNA) and ESTIMATE algorithm were applied to identify the key genes associated with the immune scores. The correlation between key genes and 22 immune cell types were estimated by using CIBERSORT algorithms.Results: WGCNA showed that the pink module was most correlated with the immune score. Seven of 14 key genes (FCRL3, IFNG, KCNA3, LY9...
Serous ovarian cancer is the most common and primary death type in ovarian cancer. In recent studies...
Ovarian cancer (OC) is the fifth leading cause of death in females. This study aims to identify new ...
The expected five-year survival rate from a stage III ovarian cancer diagnosis is a mere 22%; this a...
Immune infiltration of ovarian cancer (OV) is a critical factor in determining patient's prognosis. ...
Ovarian cancer (OC) is the second leading cause of death in gynecological cancer. Multiple study hav...
Background: Ovarian cancer (OV) is the most lethal gynecological cancer in women. We aim to develop ...
Fengjuan Shi,1,* Tongning Deng,2,* Jian Mo,1 Huiru Wang,1 Jianxun Lu3,4 1Department of Gynae...
Immune checkpoint blocking (ICB) immunotherapy has achieved great success in the treatment of variou...
Background: Ovarian cancer (OC) is the most troubling malignant tumor of the female reproductive sys...
Background: Ovarian cancer (OC) is the most troubling malignant tumor of the female reproductive sys...
Objective: To understand the immune characteristics of the ovarian cancer (OC) microenvironment and ...
Ovarian cancer is the leading cause of pelvic gynecological cancer death in Europe. Prognosis is poo...
Ovarian cancer (OV) is the most lethal form of gynecological malignancy worldwide, with limited ther...
Background: Ovarian cancer (OC) is the most troubling malignant tumor of the female reproductive sys...
Background Human epithelial ovarian cancer cell line SKOV3.ip1 is more invasive and metastatic compa...
Serous ovarian cancer is the most common and primary death type in ovarian cancer. In recent studies...
Ovarian cancer (OC) is the fifth leading cause of death in females. This study aims to identify new ...
The expected five-year survival rate from a stage III ovarian cancer diagnosis is a mere 22%; this a...
Immune infiltration of ovarian cancer (OV) is a critical factor in determining patient's prognosis. ...
Ovarian cancer (OC) is the second leading cause of death in gynecological cancer. Multiple study hav...
Background: Ovarian cancer (OV) is the most lethal gynecological cancer in women. We aim to develop ...
Fengjuan Shi,1,* Tongning Deng,2,* Jian Mo,1 Huiru Wang,1 Jianxun Lu3,4 1Department of Gynae...
Immune checkpoint blocking (ICB) immunotherapy has achieved great success in the treatment of variou...
Background: Ovarian cancer (OC) is the most troubling malignant tumor of the female reproductive sys...
Background: Ovarian cancer (OC) is the most troubling malignant tumor of the female reproductive sys...
Objective: To understand the immune characteristics of the ovarian cancer (OC) microenvironment and ...
Ovarian cancer is the leading cause of pelvic gynecological cancer death in Europe. Prognosis is poo...
Ovarian cancer (OV) is the most lethal form of gynecological malignancy worldwide, with limited ther...
Background: Ovarian cancer (OC) is the most troubling malignant tumor of the female reproductive sys...
Background Human epithelial ovarian cancer cell line SKOV3.ip1 is more invasive and metastatic compa...
Serous ovarian cancer is the most common and primary death type in ovarian cancer. In recent studies...
Ovarian cancer (OC) is the fifth leading cause of death in females. This study aims to identify new ...
The expected five-year survival rate from a stage III ovarian cancer diagnosis is a mere 22%; this a...